Advances in vascular cognitive impairment 2007

Stroke

Volumn 39, Issue 2, 2008, Pages 279-282

  Gorelick, Philip B ^a   Bowler, John V ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Neuroimaging; Risk factors; Treatment; Vascular cognitive impairment

Indexed keywords

AMYLOID; ANTIHYPERTENSIVE AGENT; GALANTAMINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANISOTROPY; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COGNITIVE DEFECT; DEMENTIA; HUMAN; LEUKOARAIOSIS; LIFESTYLE; NEUROPATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VASCULAR AMYLOIDOSIS; NEUROLOGY; STROKE;

COGNITION DISORDERS; HUMANS; NEUROLOGY; RISK FACTORS; STROKE;

EID: 39349086843     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.509570     Document Type: Review

References (52)